The mouse vas deferens: a pharmacological preparation sensitive to nociceptin

By Calo G.   Rizzi A.   Bogoni G.   Neugebauer V.   Salvadori S.   Guerrini R.   Bianchi C.   Regoli D.  

European Journal of Pharmacology, Vol. 311, Iss. 1, 1996-09 ,pp. : 3-5

Elsevier

Access to resources Recommend Favorite

In vitro agonist effects of nociceptin and [Phe 1 (CH 2 -NH)Gly 2 ]nociceptin(1-13)NH 2 in the mouse and rat colon and the mouse vas deferens

By Menzies J.R.W.   Glen T.   Davies M.R.P.   Paterson S.J.   Corbett A.D.  

European Journal of Pharmacology, Vol. 385, Iss. 2, 1999-12 ,pp. : 217-223

Elsevier

Access to resources Recommend Favorite

Evidence for atypical endothelin receptors and for presence of endothelin-converting enzyme activity in the mouse isolated vas deferens

By Maas J.   D'Orleans-Juste P.   Yano M.   Rae G.A.  

European Journal of Pharmacology, Vol. 276, Iss. 1, 1995-03 ,pp. : 113-121

Elsevier

Access to resources Recommend Favorite

Further evidence for the presence of cannabinoid CB 1 receptors in mouse vas deferens

By Pertwee R.G.   Joe-Adigwe G.   Hawksworth G.M.  

European Journal of Pharmacology, Vol. 296, Iss. 2, 1996-01 ,pp. : 169-172

Elsevier

Access to resources Recommend Favorite

A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens

By Pertwee R.G.   Griffin G.  

European Journal of Pharmacology, Vol. 272, Iss. 1, 1995-01 ,pp. : 67-72

Elsevier

Access to resources Recommend Favorite